How can the bioavailability of timolol be enhanced? A pharmacokinetic pilot study of novel hydrogels

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 234, Issue 7, 1996, Pages 452-456

  Von Der Ohe, Nicola ^a   Stark, Martin ^a   Mayer, Hans ^a   Brewitt, Horst ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CHINCHILLA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; GELS; MALE; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; RANDOM ALLOCATION; TIMOLOL;

EID: 0029894468     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02539412     Document Type: Article

References (26)

1. Burstein N, Anderson J (1985) Review: corneal penetration and ocular bioavailability of drugs. J Ocul Pharmacol 1:309-326
2. Chang S-C, Lee VHL (1986) Vehicle factors influencing the systemic absorption of topically applied timolol in the pigmented rabbit. 1st National Meeting, American Association of Pharmaceutical Scientists 3; pp 865
3. Chrai SS, Robinson JR (1974) Ocular evaluation of methylcellulose vehicle in albino rabbits. J Pharm Sci 63:1218-1223
4. Davies NM, Farr SJ, Hadgraft J, Kellaway IW (1991) Evaluation of mucoadheive polymers in ocular drug delivery. I. Viscous solutions. Pharm Res 8:1039-1043
5. Elena PP, Polzer H, Khosravi E (1993) Bioequivalence between timolol maleate formulated in ophthalmic solution (Timoptol) and a novel gel vehicle (T-Gel). Invest Ophthalmol Vis Sci 94: 1490
6. Giroux J, Schrenzel M (1964) Hydrogels à base de polymères de l'acide acrylique. Essais galémques et pharmacodynamiques. 2e communication. Pharm Acta Helv 39:615-621
7. Gurny R, Ibrahim H, Aebi A, Buri P. Wilson CG, Washington N. Edman P. Camber O (1987) Design and evaluation of controlled release systems for the eye. J Control Rel 6: 367-373
8. Hui H-W, Robinson JR (1985) Ocular delivery of progesterone using a bioadhesive polymer. Int J Pharm 26:203-213
9. Kyyrönen K, Urtti A (1990) Improved ocular:systemic absorption ratio of timolol by viscous vehicle and phenylephrine. Invest Ophthalmol Vis Sci 31: 1827-1832
10. Lee VHL (1990) Review: new directions in the optimization of ocular drug delivery. J Ocul Pharmacol 6: 157-164
11. Mayer H, von der Ohe N (1993) Wirksamkeit von Timolol in neuartiger Gelformulieruns. Ophthalmologe 90 [Suppl 1]: 103
12. Ohdo S, Grass G, Lee VHL (1991) Improving the ocular to systemic ratio of topical timolol by varying the dosing time. Invest Ophthalmol Vis Sci 32. 2790-2798
13. Patton T, Robinson J (1975) Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J Pharm Sci 64:1312-1316
14. Robinson JR, Li VHK (1984) Ocular disposition and bioavailability of pilocarpine from piloplex and other sustained release drug delivery systems. In: Tich U, David R (eds) Recent advances in glaucoma. Elsevier, Amsterdam, pp 231-236
15. Ros FE, Innemee HC, Van Zwieten PA (1979) Ocular penetration of β-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol. Doc Ophthalmol 48:291-301
16. Rozier A, Mazuel C, Grove J, Plazonnet B (1989) Gelrite: a novel ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharm 57:163-168
17. Saettone MF, Chetoni P, Torracca MT, Burgalassi S, Giannaccini B (1989) Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int J Pharm 51:203-212
18. Saettone MF, Giannaccini B, Barattini F, Tellini N (1982) The validity of rabbits for investigations on ophthalmic vehicles: a comparison of four different vehicles containing tropicamide in humans and rabbits. Pharm Acta Helv 57:47-55
19. Saeuone MF, Giannaccini B, Teneggi A, Savigni R Tellini N (1982) Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man. J Pharm Pharmacol 34:464-466
20. Saettone MF, Giannaccini B, Ravecca S, La Marca F, Tota G (1984) Polymer effects on ocular bioavailability - the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and in rabbits. Int J Pharm 20: 187-202
21. Saettone MF, Giannaccini B, Guiducci A, Savigni P (1986) Semisolid ophthalmic vehicles. III. An evaluation of four organic hydrogels containing pilocarpine. Int J Pharm 31:261-270
22. Schmitt CJ, Lotti VJ, Le Douarec JC (1980) Penetration of timolol into the rabbit eye. Measurements after ocular instillation and intravenous injection. Arch Ophthalmol 98:547-551
23. Schoenwald RD, Boltralik JJ (1979) A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations. Invest Ophthal-mol Vis Sci 18:61-66
24. Schoenwald RD, Ward RL, De Santis LM, Roehrs RE (1978) Influence of high-viscosity vehicles on miotic effect of pilocarpine. J Pharm Sci 67:1280-1283
25. Schrenzel M (1964) Hydrogels à base de polymères de l'acide acrylique. Essais galéniques et pharmacodynamiques. lère communication. Pharm Acta Helv 39:546-555
26. Vareilles P, Silverstone D, Plazonnet B, Le Douarec J-C, Sears ML, Stone CA (1977) Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit. Invest Ophthalmol Vis Sci 16:987-996